Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
Clinical trial NCT03806179 · COMPLETED
Trial details
- NCT number
- NCT03806179
- Sponsor
- Nordic Nanovector
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2022-08-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.